This may explain why 2/3 patients experienced pulmonary edema, which might have been a result of “on-target, off-tumor” toxicity as EphA2 is not usually expressed on normal tissue except on lung epithelium and preclinical studies had suggested this as a consequence [190]. The gene discussed is EPHA2; the disease is neoplasm.